LI Xiaojie
No ORCID on file
· 24 papers in corpus
· active 2006-2008
Frequent coauthors
- SUI ZHIHUA 24
- ZHANG Xuqing 24
2008
The present invention is directed to novel heterocyclic benzo[c]chromene derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders mediated by one or more estrogen receptors. The compounds of the i…
2008
The present invention is directed to novel heterocyclic benzo[c]chromene derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders mediated by one or more estrogen receptors. The compounds of the i…
2008
The present invention is directed to novel heterocyclic benzo[c]chromene derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders mediated by one or more estrogen receptors. The compounds of the i…
2008
The present invention is directed to novel heterocyclic benzo[c]chromene derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders mediated by one or more estrogen receptors. The compounds of the i…
2008
The present invention is directed to novel heterocyclic benzo[c]chromene derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders mediated by one or more estrogen receptors. The compounds of the i…
2008
The present invention is directed to novel heterocyclic benzo[c]chromene derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders mediated by one or more estrogen receptors. The compounds of the i…
2008
The present invention is directed to novel heterocyclic benzo[c]chromene derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders mediated by one or more estrogen receptors. The compounds of the i…
2008
The present invention is directed to novel heterocyclic benzo[c]chromene derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders mediated by one or more estrogen receptors. The compounds of the i…
2008
The present invention is directed to novel heterocyclic benzo[c]chromene derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders mediated by one or more estrogen receptors. The compounds of the i…
2008
The present invention is directed to novel heterocyclic benzo[c]chromene derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders mediated by one or more estrogen receptors. The compounds of the i…
2008
The present invention is directed to novel heterocyclic benzo[c]chromene derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders mediated by one or more estrogen receptors. The compounds of the i…
2008
The present invention is directed to novel heterocyclic benzo[c]chromene derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders mediated by one or more estrogen receptors. The compounds of the i…
2006
The present invention is directed to novel heterocyclic benzo[c]chromene derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders mediated by one or more estrogen receptors. The compounds of the i…
2006
The present invention is directed to novel heterocyclic benzo[c]chromene derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders mediated by one or more estrogen receptors. The compounds of the i…
2006
The present invention is directed to novel heterocyclic benzo[c]chromene derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders mediated by one or more estrogen receptors. The compounds of the i…
2006
The present invention is directed to novel heterocyclic benzo[c]chromene derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders mediated by one or more estrogen receptors. The compounds of the i…
2006
The present invention is directed to novel heterocyclic benzo[c]chromene derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders mediated by one or more estrogen receptors. The compounds of the i…
2006
The present invention is directed to novel heterocyclic benzo[c]chromene derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders mediated by one or more estrogen receptors. The compounds of the i…
2006
The present invention is directed to novel heterocyclic benzo[c]chromene derivativesof Formula (I), pharmaceutical compositions containing them and their use inthe treatment of disorders mediated by one or more estrogen receptors. The compo…
2006
The present invention is directed to novel heterocyclic benzo[c]chromene derivativesof Formula (I), pharmaceutical compositions containing them and their use inthe treatment of disorders mediated by one or more estrogen receptors. The compo…
2006
The present invention is directed to novel heterocyclic benzo[c]chromene derivativesof Formula (I), pharmaceutical compositions containing them and their use inthe treatment of disorders mediated by one or more estrogen receptors. The compo…
2006
The present invention is directed to novel heterocyclic benzo[c]chromene derivativesof Formula (I), pharmaceutical compositions containing them and their use inthe treatment of disorders mediated by one or more estrogen receptors. The compo…
2006
The present invention is directed to novel heterocyclic benzo[c]chromene derivativesof Formula (I), pharmaceutical compositions containing them and their use inthe treatment of disorders mediated by one or more estrogen receptors. The compo…
2006
The present invention is directed to novel heterocyclic benzo[c]chromene derivativesof Formula (I), pharmaceutical compositions containing them and their use inthe treatment of disorders mediated by one or more estrogen receptors. The compo…